capecitabine
Showing 1 - 25 of 896
Colorectal Cancer, Colorectal Cancer Stage IV Trial (Fruquintinib Plus Capecitabine, Capecitabine)
Not yet recruiting
- Colorectal Cancer
- Colorectal Cancer Stage IV
- Fruquintinib Plus Capecitabine
- Capecitabine
- (no location specified)
Jul 9, 2022
Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)
Not yet recruiting
- Recurrent Metastatic Nasopharyngeal Carcinoma
- Mitoxantrone hydrochloride liposome injection
- Capecitabine
- (no location specified)
Jan 29, 2023
Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ivaltinostat
- Capecitabine
- (no location specified)
Feb 10, 2022
Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)
Recruiting
- Metastatic Colorectal Cancer
- Cetuximab
- Capecitabine
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)
Recruiting
- Nasopharyngeal Carcinoma
- Sintilimab
- Capecitabine
-
Guangzhou, Guangdong, ChinaDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022
Pseudomyxoma Peritonei Trial in Milano (Capecitabine)
Recruiting
- Pseudomyxoma Peritonei
- Capecitabine
-
Milano, MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022
Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)
Recruiting
- Hormone Receptor-positive Breast Cancer
- Cemiplimab
- Capecitabine
-
Tampa, FloridaMoffitt Cancer Center
Jul 27, 2022
Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))
Recruiting
- Cholangiocarcinoma, Intrahepatic
- Capecitabine
- PD-1 Antibody(Tislelizumab)
-
Shanghai, ChinaLulu@Huashan.Org.Cn
Aug 16, 2022
Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,
Recruiting
- Biliary Tract Cancer (CCA)
- +4 more
- Durvalumab
- +2 more
-
Frankfurt am Main, GermanyKrankenhaus Nordwest
Jun 23, 2022
Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1
Recruiting
- Radiotherapy
- +3 more
- SBRT radiotherapy + Conventionally fractionated radiotherapy
- +2 more
-
Zhuhai, Guangdong, ChinaFifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022
Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract
Recruiting
- Biliary Tract Neoplasms
- +3 more
- S-1
- Capecitabine
-
Shanghai, ChinaHuashan hospital
Aug 16, 2022
Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)
Not yet recruiting
- Triple Negative Breast Cancer
- Capecitabine
- Tucidinostat
-
Guangzhou, Guangdong, ChinaSun-yat sen university cancer center
Jun 5, 2022
Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China
Recruiting
- Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
- LBL-007
- +3 more
-
Benowa, Queensland, Australia
- +7 more
Jan 30, 2023
Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)
Active, not recruiting
- Glioblastoma
- Capecitabine
- Bevacizumab
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 22, 2022
Breast Cancer, Chemo Effect Trial (Capecitabine)
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Capecitabine
- (no location specified)
Mar 9, 2022
Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)
Not yet recruiting
- Breast Cancer
- Tucidinostat
- +2 more
-
Guangzhou, Gangdong, ChinaShusen Wang
Jun 17, 2022
Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)
Active, not recruiting
- Elderly Metastatic Colorectal Cancer Patients
- Capecitabine
- +2 more
-
Padua, ItalyIstituto Oncologico Veneto IRCCS
Mar 30, 2022
Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Feb 10, 2022
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Triple Negative Breast Cancer, Breast Cancer Trial in Stanford (Capecitabine)
Recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Capecitabine
-
Stanford, CaliforniaStanford University
Jan 7, 2022
Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)
Not yet recruiting
- Triple-negative Breast Cancer
- chidamide
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 25, 2022
Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- Unresectable Pancreatic Neuroendocrine Carcinoma
- Lutetium Lu 177 Dotatate
- +4 more
- (no location specified)
Feb 10, 2022
Metastatic Triple-Negative Breast Cancer Trial in Beijing (Anlotinib, Capecitabine)
Recruiting
- Metastatic Triple-Negative Breast Cancer
- Anlotinib
- Capecitabine
-
Beijing, Beijing, China
- +1 more
Dec 18, 2021
Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)
Recruiting
- Adenocarcinoma
- +9 more
- Nab-paclitaxel
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 15, 2022